These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10464352)

  • 21. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.
    Takaishi H; Matsuki T; Nakazawa A; Takada T; Kado S; Asahara T; Kamada N; Sakuraba A; Yajima T; Higuchi H; Inoue N; Ogata H; Iwao Y; Nomoto K; Tanaka R; Hibi T
    Int J Med Microbiol; 2008 Jul; 298(5-6):463-72. PubMed ID: 17897884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.
    Rioux KP; Madsen KL; Fedorak RN
    Gastroenterol Clin North Am; 2005 Sep; 34(3):465-82, ix. PubMed ID: 16084308
    [No Abstract]   [Full Text] [Related]  

  • 23. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the role of the enteric commensal flora in IBD?
    Guarner F
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S83-4. PubMed ID: 18816773
    [No Abstract]   [Full Text] [Related]  

  • 25. A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease?
    Kalischuk LD; Buret AG
    Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G1-9. PubMed ID: 19875702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunopathogenesis of inflammatory bowel diseases: new approaches for therapy?].
    Beglinger C
    Schweiz Med Wochenschr; 1998 Jan; 128(1-2):11-4. PubMed ID: 9491461
    [No Abstract]   [Full Text] [Related]  

  • 27. Bacteria in the pathogenesis of inflammatory bowel disease.
    Subramanian S; Campbell BJ; Rhodes JM
    Curr Opin Infect Dis; 2006 Oct; 19(5):475-84. PubMed ID: 16940872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip.
    Kim HJ; Li H; Collins JJ; Ingber DE
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E7-15. PubMed ID: 26668389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of inflammatory bowel disease with antibiotics.
    Isaacs KL; Sartor RB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):335-45, x. PubMed ID: 15177542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbes, intestinal inflammation and probiotics.
    Khan MW; Kale AA; Bere P; Vajjala S; Gounaris E; Pakanati KC
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):81-94. PubMed ID: 22149584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the role of the metabolic activity of the gut microbiota in inflammatory bowel disease? Probing for answers with stable isotopes.
    Barclay AR; Morrison DJ; Weaver LT
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):486-95. PubMed ID: 18493202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse models of inflammatory bowel disease for investigating mucosal immunity in the intestine.
    Bamias G; Arseneau KO; Cominelli F
    Curr Opin Gastroenterol; 2017 Nov; 33(6):411-416. PubMed ID: 28901966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.
    Ott SJ; Musfeldt M; Wenderoth DF; Hampe J; Brant O; Fölsch UR; Timmis KN; Schreiber S
    Gut; 2004 May; 53(5):685-93. PubMed ID: 15082587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?
    Fantini MC; Monteleone G
    Inflamm Bowel Dis; 2017 Oct; 23(10):1682-1688. PubMed ID: 28906289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease.
    Hirata Y; Ihara S; Koike K
    Pharmacol Res; 2016 Nov; 113(Pt A):574-584. PubMed ID: 27702681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria?
    Blum S; Schiffrin EJ
    Curr Issues Intest Microbiol; 2003 Sep; 4(2):53-60. PubMed ID: 14503689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the gut microbiome on mucosal inflammation.
    Strober W
    Trends Immunol; 2013 Sep; 34(9):423-30. PubMed ID: 23957963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Touch of Youth in Gut Microbiota Development.
    Magri G; Cerutti A
    Immunity; 2016 Jul; 45(1):12-4. PubMed ID: 27438763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.